Boston · Seed–Late Stage · 7 people tracked
Also known as EXCEL VENTURE MANAGEMENT, LLC
Find your way into Excel Venture Management
1,093 people in our graph share verified history with the Excel Venture Management team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Excel Venture Management focuses on building companies that leverage transformative life science technologies to address challenges in healthcare and beyond. Its investment portfolio is diversified across several categories, including healthcare IT and services, diagnostics, medical devices, and life science platforms.
Source: firm website, verified Sep 15, 2026.
Team · 7 people
from the firm's website & public directories
What they invest in
from 19 of 32 portfolio companiesHealthtech ×12Biotech ×8Digital Health ×6AI & Machine Learning ×4Medical Devices ×4Enterprise Software ×3Consumer ×2Cybersecurity ×2
HQs:United States×20Canada×1Netherlands×1
Investments · 32 tracked
founders shown can be your intro pathBy year:2023 · 22020 · 12018 · 22017 · 12016 · 22015 · 22014 · 212 dated
Aileron Therapeutics is a clinical-stage biopharmaceutical company developing peptide and protein-based therapies for rare lung and fibrosis diseases.
BiotechCambridge, US
Manuel Aivado(Executive Officer)inBrian Windsor(President and Chief Executive Officer; Director)in
BoardSeth L. Harrison(Director)Reinhard J. Ambros(Director)Joseph A. Yanchik III(Executive Officer, Director)in
Board seatCaleb Winder· per SEC Form D
Co-investorsNovartis Venture Fund
MetaVia is a clinical-stage biotechnology company developing therapeutics for cardiometabolic diseases, including DA-1726 for obesity and vanoglipel (DA-1241) for Metabolic Dysfunction-Associated Steatohepatitis (MASH).
BiotechHealthtechCambridge, US
Mina Sooch(Executive Officer)Hyung Heon Kim(Executive Officer, Director)Margaret McShane(Executive Officer)David Lowenschuss(Executive Officer)Marshall Woodworth(Chief Financial Officer)Charles Bisgaier(Executive Officer)
Board seatSteve Gullans· per SEC Form D · $12.5M raise · filed Mar 2017
Co-investorsGREAT LAKES BAY VENTURE
Agilent manufactures laboratory instruments, software, reagents, and consumables for pharmaceutical, diagnostics, clinical research, and applied markets including chemicals, food, and environmental sectors.
William Redington HewlettPadraig McDonnell(President and Chief Executive Officer)
Co-investorsCalifornia Technology VenturesCatalyst Health VenturesLAV
ClearDATA is a cloud security and compliance platform purpose-built for healthcare organizations.
Cloud ComputingCybersecurityDigital HealthHealthtech
Rick Froehlich(President & Chief Executive Officer)inJim Ducharme(Chief Technology Officer)inGregg Bjork(Chief Revenue Officer)inDrew Schaal(Chief Financial Officer)inCarol Boone(Vice President of People)in
Co-investorsFlare Capital PartnersNorwest Venture PartnersMerck Global Health Innovation FundHLM Venture Partners
Qstream offers a microlearning platform with AI tools that turn existing content into short, scenario-based training courses.
AI & Machine LearningEdTechSaaSBurlington, US
Duncan Lennox(Executive Officer, Director, Promoter)inBranch Price Kerfoot(Director)
BoardHambleton Lord(Director)inShay Garvey(Director)inGaye Bok(Director)Harold Copperman(Director)
Co-investorsDelta PartnersLaunchpad Venture GroupEnterprise IrelandBantam GroupFrontline VenturesPolaris Partners
Censinet provides risk management solutions for healthcare organizations, built by former healthcare operators and security experts who understand the integrated risks healthcare systems face.
CybersecurityEnterprise SoftwareHealthtechSaaSBoston, US
Ed Gaudet(Founder)inCambrey Warein
Board seatCaleb Winder· per SEC Form D · $9M raise · filed Jan 2023
Co-investorsBallad VenturesExcelerate Health VenturesHLM Venture PartnersMemorialCare Innovation FundSchooner CapitalLRVHealth+1 more
InfoBionic.Ai develops a remote cardiac monitoring platform called MoMe ARC that combines AI-powered ECG analysis, interchangeable biosensors, and clinical analytics to enable hospital-grade cardiac telemetry outside traditional hospital settings.
AI & Machine LearningHealthtechMedical DevicesLowell, US
Steven Wasserman(Executive Officer)Nancy Briefs(Executive Officer, Director)
BoardCarl Berke(Director)Al Wiegman(Director)Hamid Tabatabaie(Director)
Board seatCaleb Winder· per SEC Form D
Co-investorsBroadview VenturesHealthtech CapitalKeiretsu Forum
Houston, US
David Eagleman(Executive Officer, Director)Scott Novich(Executive Officer, Director)
BoardJon Callaghan(Director)in
Board seatJuan Enriquez· per SEC Form D
Co-investorsHCVCWestern Technology InvestmentDigiTx Partners LLCTrue Ventures
Welldoc develops an AI-driven digital health platform focused on cardiometabolic disease management, providing personalized treatment solutions for patients with diabetes and related conditions.
AI & Machine LearningDigital HealthHealthtechBaltimore, US
Ryan Sysko(Executive Officer, Director)inSuzanne Clough(Executive Officer)inKevin McRaith(President and CEO)inAnand Iyer(Chief AI Officer)inChris Bergstrom(Executive Officer)in
.png){kind=avatar}
-min.jpg){kind=avatar}
BoardTerry Lierman(Director)
Board seatJuan Enriquez· per SEC Form D
Co-investorsMerck Global Health Innovation FundSamsung VenturesAsset Management CompanyDigiTx Partners LLCTCP Venture CapitalWindham Capital Partners+1 more
McKesson distributes pharmaceuticals and medical supplies to pharmacies, hospitals, doctors' offices and clinics across North America, and provides technology and services covering specialty and cancer care, medication access and affordability, and pharmacy financial support.
Digital HealthHealthtechLogistics & Supply Chain
Co-investorsNew Capital Partners
Cleveland HeartLab provides diagnostic blood tests that use a multimarker approach, including inflammatory biomarkers such as hsCRP and MPO, to assess and stratify an individual's cardiovascular disease risk.
BiotechDigital HealthHealthtechCleveland, US
Rebecca Holland(Executive Officer)Pamela Gornall(Executive Officer)Jacob Orville(Executive Officer, Director)
BoardSteve Gullans(Director)William Cadogan(Director)Gus Lawlor(Director)
Co-investorsMutual Capital PartnersAdvantage Capital PartnersHealthCare Ventures, LLC
IlluminOss Medical makes a light-curable, patient-conforming intramedullary implant for minimally invasive fracture repair.
Co-investorsLongwood FundSlater Technology Fund
Philips develops health technology and consumer products for patients, healthcare providers, and households, with an emphasis on durable, recyclable products.
Circular EconomyConsumerHealthtechMedical DevicesAmsterdam, NL
Co-investorsNew Enterprise Associates (NEA)Sanderling Ventures
BiotechAustin, US
Eric E. Poma(Executive Officer, Director)Jason S. Kim(Executive Officer)David R. Hoffmann(Director)David Hirsch(Director)David Valacer(Executive Officer)Harold Selick(Director)
Co-investorsSante Health Ventures
Openwater develops an imaging platform using two optical modalities designed to diagnose and monitor diseases at the size and cost of a smartphone.
AI & Machine LearningDeep TechHardwareHealthtechMedical DevicesSan Francisco, US
Dr. Mary Lou Jepsen(Executive Chairman & Founder)in
Co-investorsAIR CapitalBold Capital PartnersCollaborative FundLauder PartnersPlum Alley InvestmentsResolute Ventures+3 more
Orionis Biosciences discovers and engineers molecules that connect proteins on or within cells to reprogram disease-driving processes or activate immune responses.
BiotechDeep TechNewton, US
Nikolai Kley(Founder)inNikolai Kley, Ph.D.(Executive Officer, Director)
BoardGriet Vanpoucke, Ph.D.(Director)Steven R. Gullans, Ph.D.(Director)
Co-investorsSolari CapitalSolasta VenturesV-Bio VenturesWessel Management
Saladax Biomedical develops blood-level tests that help psychiatrists and oncologists determine correct individual drug dosages based on patient metabolism, supporting treatment decisions and reducing toxicity risk.
BiotechDigital HealthHealthtechMedical Devices
Co-investorsLife Sciences Greenhouse InvestmentsGolden Seeds
Shape is a digital wellness media publication offering science-backed articles, product reviews, and expert advice on fitness, health, and wellness.
ConsumerMedia & EntertainmentWellness & FitnessNew York, US
Co-investorsBeechwood CapitalCue Ball
Synthetic Genomics provides independent reviews and research on online casinos in Canada, focusing on payment methods, licensing, payout speed, and responsible gambling protections rather than promotional bonuses.
Marketplaces
Thermo Fisher provides life science products and laboratory equipment, including antibodies, consumables, biobanking resources, and Cryo-EM imaging systems for research labs and scientists.
BiotechEnterprise SoftwareHardwareHealthtechWaltham, US
Anthony Uzzo(Executive Officer, Director)inJoshua Geballe(Executive Officer, Director)James Gregory(Executive Officer, Director)Marc N. Casper(Executive Officer, Director)inAndrew J. Thomson(Executive Officer)Peter M. Wilver(Executive Officer)
Co-investorsARCH Venture PartnersBayMed Venture PartnersCross Creek AdvisorsHeran PartnersOak HC/FTDomain Associates+2 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Farmer Willie'sShapeUpZipongoDnaeGemphireLantos TechnologiesTetraphase PharmaceuticalsTphaseVirgin Pulse
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 6
3 IPOs · 3 acquisitions · showing 4Aileron TherapeuticsNASDAQ: RNTXNeuroBo PharmaceuticalsNASDAQ: MTVAAgilentNYSE: ATetraphase Pharmaceuticalsacq. by La Jolla Pharmaceutical Company
Portfolio news
latest coverage across their companiesAgilent · investing.com · Sep 16, 2026
Thermo Fisher Scientific · investing.com · Sep 16, 2026
Shape · finance.biggo.com · Aug 24, 2026
ClearDATA · funderintel.com · Jul 16, 2026
Molecular Templates · ad-hoc-news.de · Jun 2, 2026
Neosensory · trysignalbase.com · Mar 26, 2025
Frequently asked questions
- How many investments has Excel Venture Management made?
- Excel Venture Management has 32 tracked investments, 6 of which have exited.
- What stage does Excel Venture Management invest at?
- Excel Venture Management invests at the Seed, Series A, Series B, Series C, Late Stage stages.
- What is Excel Venture Management's typical check size?
- Excel Venture Management typically writes checks of $1M – $5M.
- What sectors does Excel Venture Management focus on?
- Excel Venture Management focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Excel Venture Management located?
- Excel Venture Management is headquartered in Boston, US.
- Who does Excel Venture Management co-invest with?
- Excel Venture Management most often shares deals with New Enterprise Associates (NEA), Bessemer Venture Partners, Collaborative Fund, among 41 tracked co-investors.
Media · Podcasts & interviews
featuring the teamJuan Enriquez, Managing Director of Excel Venture Management, LLC, advises all #innovators
The INNOVATORS · Juan Enriquez
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.
T. Rowe Price is a global asset management firm that actively invests across markets to pursue opportunities on behalf of its clients.
New Alliance Capital is a Shanghai-based private equity and venture capital firm founded in 2008, focused on technology-driven sectors. Its backers include state-owned enterprise groups, insurance capital, fund-of-funds, government guidance funds, and listed companies.
Bay City Capital is a venture capital firm founded in 1997 that has raised five venture funds totaling $1.3 billion in capital commitments and invested in more than 100 companies worldwide.